Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy
ObjectiveA new Tripterygium wilfordii preparation called Kunxian capsule (KX) has been approved in China. However, it is still unknown whether KX is safe and effective for idiopathic membranous nephropathy (IMN) and its therapeutic mechanism of action is unclear.MethodsWe conducted a retrospective s...
Saved in:
Main Authors: | Jia Lv, Xinyu Gao, Lihua Liu, Libing He, Geng Tian, Xuehong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1506972/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies
by: Xue Li, et al.
Published: (2024-12-01) -
Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
by: Xiaolong Wang, et al.
Published: (2025-01-01) -
Analysis of the mechanism of Zangjiangzhi capsule in the treatment of hyperlipidemia based on its ingredients identified by UHPLC-Q-Exactive-Orbitrap-MS
by: Changting He, et al.
Published: (2025-01-01) -
Effects of Baicalin on Gout Based on Network Pharmacology, Molecular Docking, and in vitro Experiments
by: Liu C, et al.
Published: (2025-02-01) -
Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and in vitro experiments
by: Jialiang Xin, et al.
Published: (2025-01-01)